Artblood

Developer of a cell-based extracorporeal blood production system

placeSeoul, Seoul, South Korea calendar_todayFounded 2022 language artblood.kr

Innovation

3 patent families — focus: Chemistry & metallurgy; filing pace accelerating. Cited 15 times.

YearFilings
20231
20242
20252

Investor mix

5 investors on record.

Investor typeCountShare
Private equity120%
Accelerator & incubator120%
Bank & private debt120%
Other / undisclosed240%
Coming soon